BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia. - Chong SJF; Lu J; Valentin R; Lehmberg TZ; Eu JQ; Wang J; Zhu F; Kong LR; Fernandes SM; Zhang J; Herbaux C; Goh BC; et al. (Molecular cancer, 2025)